Zejula (niraparib)
pCPA File Number:
21484
Negotiation Status:
Concluded with an LOI
Indication(s):
Ovarian Cancer: Maintenance treatment of adult patients with advanced epithelial ovarian, fallopian tube, or primary peritoneal cancer who are in a complete or partial response to first-line platinum-based chemotherapy
Sponsor/Manufacturer:
GlaxoSmithKline Inc.
CDA-AMC Project Number:
PC0224-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: